<DOC>
	<DOCNO>NCT01551823</DOCNO>
	<brief_summary>The purpose study evaluate safety immunogenicity Influenza Virus Vaccine ( Split Virion , Inactivated ) ( child form drug ) contain Preservative .</brief_summary>
	<brief_title>The Clinical Trial Protocol Influenza Virus Vaccine ( Split Virion , Inactivated ) （Children Forms Drug）</brief_title>
	<detailed_description>Influenza Virus Vaccine ( Split Virion , Inactivated ) contain Preservative . HA content 7.5μg/0.5ml per dose include H1N1、H3N2 B. Inactivated Split Influenza Vaccine manufacture Sanofi Pasteur HA content 7.5μg/0.5ml per dose include H1N1、H3N2 B . This randomized , blind phase 3 clinical trial . Total 1200 adult ( age 6 month 36 month ) select , randomize two group [ Influenza Virus Vaccine ( Split Virion , Inactivated ) Inactivated Split Influenza Vaccine , group n=600 ] , adult group vaccinate two dos either Influenza Virus Vaccine ( Split Virion , Inactivated ) Sanof IVV respectively,21 day apart .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Males female , age 6 month 35 month ; Adults , parent ( ) guardians able understand sign inform consent participation ; Participants guardians able attend plan clinical appointment obey follow study instruction ; Infants vaccinate influenza preventive biologicals recent 7 day ; Axillary temperature ≤37℃ . Have medical record participant family allergy egg , convulsion , fall sickness , encephalopathy psychopathy ; Low platelet bleed disorder allow vaccination muscle ; Have damage low immunological function ; Received blood , plasma immunoglobulin treatment since birth ; Have inborn abnormality , develop obstacle clinical diagnostic serious chronic ( Down Syndrome , diabetes , sickle cell anemia neural GuillainBarre Syndrome ) ; Have doubtful following disease : respiratory system diseases , acute infection active chronic , cardiovascular disease , liver kidney disease , skin disease , HIV . Exclusion Criteria dose 2 Have serious anaphylaxis high fever , convulsion first dose ; Have circus Exclusion Criteria Eligible study ; Have serious adverse event relate previous vaccination ; Withdrawal Discontinuance Criteria ; Received necessary interference study drug : immuneinhibition immunestimulating agent ; Vaccinated vaccine（except DTP） ; Stop observation determine investigator owe occur serious adverse event .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>35 Months</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Influenza Virus Vaccine ( Split Virion , Inactivated )</keyword>
	<keyword>Influenza</keyword>
</DOC>